CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AstraZeneca Pharmaceuticals LP v. Palmetto Pharmaceuticals LLC

1:11-cv-00294

Overview

Case Number 1:11-cv-00294
Filing Date 2011-04-07
Status Terminated
Termination Date 2014-05-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Movant

AstraZeneca Pharmaceuticals LP NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Dana Kathryn Severance

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Chad S.C. Stover

Barnes & Thornburg LLP

Tel: +1 (302) 300-3474

1000 N. West Street, Suite 1500, Wilmington, DE 19801

Mary W. Bourke

Womble Carlyle Sandridge Rice

Tel: +1 (302) 252-4320

Womble Carlyle Sandridge Rice, 222 Delaware Avenue

Defendant

Palmetto Pharmaceuticals LLC Operating Company

Represented By

1 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

The Brandywine Building, 1000 West Street, Suite 1501

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2011-04-05
2:11-cv-00807

Palmetto Pharmaceuticals LLC v. AstraZeneca Pharmaceuticals LP

Asserted Patent
Status: SCD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6465516
Method of stimulating nitric oxide synthase
Filed: 1999-10-18
Issued: 2002-10-15
Expired (Term Ended)
Expires: 2019-10-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

4

Granted

2

Denied

0

Pending / Review

2

Motions by Category

Motion to Dismiss 2 Motion to Transfer Venue (28 U.S.C. Β§ 1404) 2

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. Β§ 1404) Granted
ORDER re 12 Stipulated MOTION to Transfer Venue to The District Court for the District of South Carolina is GRANTED. Signed by Judge Leonard P. Stark on 5/16/14...
Entry #13 • 2014-05-16 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Granted
Joint MOTION to Transfer Case to The District Court for the District of South Carolina - filed by Palmetto Pharmaceuticals LLC. (Attachments: # 1 Text of Propos...
Entry #12 • 2014-05-15 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss Based upon Defendant Palmetto Pharmaceuticals LLC's Motion to Stay, Dismiss, or in the Alternative Transfer, Plaintiff's Complaint - filed by ...
Entry #6 • 2011-04-28 Document →
Motion to Dismiss Pending / Under Review
MEMORANDUM in Support re 6 MOTION to Dismiss Based upon Defendant Palmetto Pharmaceuticals LLC's Motion to Stay, Dismiss, or in the Alternative Transfer, Plaint...
Entry #7 • 2011-04-28 Document →

Docket Entries

(16 total)
Pleading / Complaint

COMPLAINT filed against Palmetto Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. (Filing fee $ 350, receipt number 0311-872186) - filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nms) (Entered: 04/07/2011)

Entry #1 • 2011-04-07
1
Pleading / Complaint

COMPLAINT filed against Palmetto Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. (Filing fee $ 350, receipt number 0311-872186) - filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nms) (Entered: 04/07/2011)

Entry #1 • 2011-04-07
2
Pleading / Complaint

COMPLAINT filed against Palmetto Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. (Filing fee $ 350, receipt number 0311-872186) - filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nms) (Entered: 04/07/2011)

Entry #1 • 2011-04-07
2
Pleading / Complaint

COMPLAINT filed against Palmetto Pharmaceuticals LLC - Magistrate Consent Notice to Pltf. (Filing fee $ 350, receipt number 0311-872186) - filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nms) (Entered: 04/07/2011)

Entry #1 • 2011-04-07
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nms) (Entered: 04/07/2011)

Entry #2 • 2011-04-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc